FDA Enhances Global Patient and Regulatory Collaborations in Oncology
4.7 (435) · $ 12.99 · In stock
In recognition of World Cancer Day 2024, the FDA and European Medicines Agency will collaborate to spotlight innovative cancer treatment advances for patients.
Fourteen biotech companies spearheading the antibody drug conjugate industry
Rx Rundown: Gilead Sciences, CG Oncology, Genentech and more
Joseph Gibbons (@perevisage) / X
Jan Geissler on LinkedIn: #xgegenkrebs #worldcancerday #xgegenkrebs #weltkrebstag #worldcancerday…
New VQIP Resource - US FDA
Kirsten Boyd Goldberg on LinkedIn: Conversations on Cancer: Cancer Disparities in Appalachia
SCRI Announces a Collaboration with AstraZeneca Focused on Technology Enhancements & Innovative Operational Model to Advance Cancer Research
FDA's Global Gene Therapy Pilot Program: Will 2024 mark the maturation of gene therapy approvals?
Good Machine Learning Practice for Medical Device Development: Guiding Principles from the FDA
SBIA, Next Week - Overview: Clinical Pharmacology Considerations for Food Effect Studies Webinar - Earn 1 hour of CME, CNE
Maria Golovina, MS MBA on LinkedIn: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
Caroline Voltz-Girolt on LinkedIn: FDA Enhances Global Patient and Regulatory Collaborations in Oncology
